Ann: Q4 Briefing 2020, page-4

What an absolutely awesome presentation today. The Professor is the real deal!!! No brainer for me.

I'm holding on tight to this top 'growth' stock!!! Why?

• UCM is tightly held by experienced investors; (follow the smart money)
• Profitable, cash flow positive, record cash receipts, cash on hand and debt free; $$$$
• Continuing strong growth forecasts for Uscom China; $$$$
• Europe and US distribution showing sales pipeline growth (COVID-19); $$$$
• New products for global markets – BP+, SpiroSonicAIR and VENTITEST;

- BP+ developed to set new standards - hypertension. $130B spent on US hypertension and 20% of hyperensives have controlled BP - SpiroSonicAIRfor the acute and chronic recovery phases of COVID-19 (5000 unit sales ~$10M revenue) $$$$
- VENTITEST for calibration of ventilators (Estimated 10,000 unit sales = $25M revenue) $$$$

Oh, and it's a medical device company that's actually helping people and saving lives - so an ethical investment too.

GLTAH